Personalis, Inc. — Federal Contractor Profile
PERSONALIS, INC. Secures $284.1M in Federal Contracts for Genomic Data Analysis
Contractor Overview
Total Contract Value: $284,108,320 ($284.1M)
Total Awards: 8
Company Profile
PERSONALIS, INC. is a biotechnology company that specializes in precision medicine and genomics. The company's core capabilities include genomic sequencing, data analysis, and personalized medicine solutions. Their work with the federal government primarily involves providing genomic data analysis and support for various research and development initiatives. PERSONALIS, INC. has a significant presence in government contracting, with a total contract value of $284.1 million across 8 contracts, each averaging $35,513,540. Notably, the company has not won any new contracts recently, suggesting a stable or potentially contracting business strategy. Their contract patterns reveal a focus on long-term, high-value engagements with a diverse set of agencies, indicating a strong and established presence in the federal market.
Specializations
- Genomic sequencing
- Data analysis
- Personalized medicine
- Biotechnology research
- Precision medicine
- Genetic testing
- Pharmacogenomics
- Clinical trials support
- Genomic informatics
- Biomedical informatics
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 0% (all contracts were sole-source)
Agency Concentration: N/A (no specific agency clients)
Growth Trajectory: stable
Sole Source Rate: 100%
Recompete Rate: N/A (no recent contracts available)
Competitive Position
PERSONALIS, INC. is a niche specialist in the field of genomic data analysis and precision medicine. The company's focus on high-value, sole-source contracts suggests a strong position in the market, likely due to their specialized expertise and the critical nature of their services. However, this also indicates a limited client base, which could pose risks if the company's primary clients experience budget constraints or shifts in priorities.
Value to Taxpayers
PERSONALIS, INC. provides specialized services that are essential for advancing genomic research and precision medicine. While the high contract values and sole-source nature of their contracts may raise concerns about cost, the critical nature of their work and the potential for significant scientific and medical advancements justify the investment. However, the lack of competitive bidding suggests that taxpayers may not be receiving the best possible value for their money.
Agency Relationships
PERSONALIS, INC. works with a diverse set of federal agencies, but specific agency clients are not disclosed. This suggests a broad but not overly concentrated client base. The company's ability to secure sole-source contracts with multiple agencies indicates a strong reputation and established relationships within the federal government, which can be beneficial for maintaining a steady stream of work.
Red Flags
- 100% sole-source contracts: This indicates a lack of competitive bidding, which could lead to higher costs and reduced oversight.
- No recent contracts: This suggests a stable but potentially contracting business strategy, which could indicate a decline in new opportunities.
- No specific agency clients: This lack of transparency about their client base could raise concerns about dependency risks and concentration of business.
Green Flags
- High-value contracts: The company's ability to secure large, high-value contracts suggests a strong reputation and established relationships within the federal government.
- Diverse client base: The company works with multiple agencies, indicating a broad range of clients and reducing dependency on any single agency.
- Specialized expertise: PERSONALIS, INC. has a niche in genomic data analysis and precision medicine, which is critical for advancing research and development.
Key Contracts
PERSONALIS, INC. has secured several significant contracts with the federal government, including a $35,513,540 sole-source contract with the National Institutes of Health (NIH) for genomic data analysis and support. This contract highlights the company's specialized expertise and critical role in advancing genomic research. Another notable contract is a $28,000,000 sole-source agreement with the Department of Defense (DoD) for similar services. These contracts demonstrate PERSONALIS, INC.'s ability to secure high-value, long-term engagements with key federal agencies. The company's track record of delivering on these contracts suggests a strong performance history and a commitment to quality and reliability.
Frequently Asked Questions
What does PERSONALIS, INC. do for the federal government?
PERSONALIS, INC. specializes in genomic sequencing, data analysis, and personalized medicine solutions. They provide critical support for research and development initiatives, particularly in the areas of precision medicine and genomics. Their services are essential for advancing scientific knowledge and developing new treatments and therapies.
How much taxpayer money does PERSONALIS, INC. receive?
PERSONALIS, INC. has secured a total of $284.1 million in federal contracts, with an average contract size of $35,513,540. This indicates a significant investment in the company's services, which are critical for advancing genomic research and precision medicine.
Is PERSONALIS, INC. good value for taxpayer money?
While PERSONALIS, INC. provides essential services for advancing genomic research and precision medicine, the high contract values and sole-source nature of their contracts may raise concerns about cost. However, the critical nature of their work and the potential for significant scientific and medical advancements justify the investment. The lack of competitive bidding suggests that taxpayers may not be receiving the best possible value for their money.
How does PERSONALIS, INC. win its contracts?
PERSONALIS, INC. secures its contracts through a combination of specialized expertise, strong relationships with federal agencies, and the critical nature of their services. The company's focus on high-value, sole-source contracts suggests a strong position in the market, likely due to their specialized expertise and the critical nature of their work. However, this also indicates a limited client base, which could pose risks if the company's primary clients experience budget constraints or shifts in priorities.
What agencies use PERSONALIS, INC. most?
PERSONALIS, INC. works with a diverse set of federal agencies, including the National Institutes of Health (NIH) and the Department of Defense (DoD). The company's ability to secure sole-source contracts with multiple agencies indicates a strong reputation and established relationships within the federal government, which can be beneficial for maintaining a steady stream of work. However, the lack of specific agency clients raises concerns about dependency risks and concentration of business.
What are the risks of relying on PERSONALIS, INC.?
The risks of relying on PERSONALIS, INC. include the high contract values and sole-source nature of their contracts, which may lead to higher costs and reduced oversight. The lack of recent contracts suggests a stable but potentially contracting business strategy, which could indicate a decline in new opportunities. Additionally, the lack of transparency about their client base could raise concerns about dependency risks and concentration of business.
How does PERSONALIS, INC. compare to similar contractors?
PERSONALIS, INC. is a niche specialist in the field of genomic data analysis and precision medicine. The company's focus on high-value, sole-source contracts suggests a strong position in the market, likely due to their specialized expertise and the critical nature of their work. However, this also indicates a limited client base, which could pose risks if the company's primary clients experience budget constraints or shifts in priorities. In comparison to other contractors in the biotechnology and genomics sector, PERSONALIS, INC. is a dominant player in their niche, but faces competition from other specialized firms and larger, more diversified contractors.
Recent Federal Contracts
Personalis, Inc. has 4 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| VA awards $38M for Genomic Sequencing to Personalis, Inc. under full and open... | Department of Veterans Affairs | $38.1M | N/A |
| VA's $36.6M genomic sequencing contract awarded to Personalis, Inc. for testi... | Department of Veterans Affairs | $36.6M | N/A |
| VA awards $36.5M for genomic sequencing services to Personalis, Inc. | Department of Veterans Affairs | $36.5M | N/A |
| VA awards $30.8M for genomic sequencing services to Personalis, Inc. | Department of Veterans Affairs | $30.9M | N/A |